| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.024 | 0.7 |